Supreme CBD Ltd
Three upheld ASA rulings (2024–2025) against Supreme CBD ads over health claims and unlabeled promotion
This entry is about the United Kingdom — not the country you picked in the header.
According to Advertising Standards Authority (UK), Feb 14, 2024 · Read the source · +3 more
- Where
- United Kingdom
- First reported
- Last checked
Summary
Supreme CBD Ltd, a UK seller of CBD products trading as Supreme CBD, has been the subject of three upheld rulings by the Advertising Standards Authority (ASA). In February 2024, the ASA found that posts on X by people promoting the brand were not clearly identified as ads and implied that CBD could help with anxiety, insomnia and depression. In November 2024, it ruled that a post by the company's director saying CBD would work for everyone and make a noticeable difference within days was a health claim not authorized for food products. In October 2025, it upheld complaints about an Instagram ad that, in the ASA's reading, suggested CBD could treat chronic anxiety and depression, compared it favorably with antidepressants and discouraged reliance on medical treatment. Each time the ASA told the company not to repeat the ads. According to the 2025 ruling, the company removed that ad after being contacted. On 1 June 2026 the ASA also listed the company as a non-compliant advertiser, saying disease-treatment claims on its website, brand social accounts and affiliate accounts, and unlabeled affiliate advertising, continued despite repeated requests from its compliance team.
What the source found
- February 14, 2024: ASA upheld three issues, including undisclosed advertising on X and claims that CBD could help with anxiety, insomnia and depression.
- November 13, 2024: ASA found a post claiming CBD would work for everyone was an unauthorized general health claim.
- October 29, 2025: ASA found an Instagram ad implied CBD could treat anxiety and depression and discouraged essential medical treatment.
- The ASA instructed the company not to claim CBD prevents, treats or cures disease and to label ads clearly.
- ASA non-compliant advertiser listing (June 2026): continues to claim CBD treats, prevents or cures disease on supremecbd.uk, brand social accounts and affiliate accounts, and fails to identify marketing clearly, despite repeated CAP Compliance requests.
Products named
- CBD products
Timeline
First ASA ruling upheld
Second ASA ruling upheld
Third ASA ruling upheld
ASA lists Supreme CBD Ltd as a non-compliant advertiser for continuing disease-treatment claims
Sources
- Regulator
Advertising Standards Authority (UK) · Feb 14, 2024
ASA Ruling on Supreme CBD Ltd (G23-1198642) - Regulator
Advertising Standards Authority (UK) · Nov 13, 2024
ASA Ruling on Supreme CBD Ltd (A24-1253019) - Regulator
Advertising Standards Authority (UK) · Oct 29, 2025
ASA Ruling on Supreme CBD Ltd - Regulator
Advertising Standards Authority · Jun 1, 2026
Non-compliant advertisers: Supreme CBD Ltd
Wording on this page follows the sources. Found an error? See the corrections process in our editorial policy.
Status notes
ASA rulings concern advertising only; they are not findings about product safety or legality of sale. The rulings name individuals (the director and well-known influencers); they are not named here.
Comments
No comments yet.
Related entries
The full Red ListVitanabis Intermediação e Serviços Ltda.
Vitanabis
Anvisa prohibited all cannabis derivatives sold by Vitanabis and advertised online
Leve CDB
Leve CDB
Anvisa prohibited the Leve CDB Full Spectrum cannabis oil 6,000 mg sold through its official website
Cannabis Oil
cpag.supersalelinks[.]org/ujih/
Listed by Czech medicines regulator SÚKL as a website illegally offering an unapproved 'Cannabis Oil' preparation
Tell us what happened
Every report is read by a person. You don’t need to prove anything, and we never publish your name.
- A moderator reads your report and checks the link against the Red List and our seller records.
- We look for an authoritative source — a regulator, court, police or consumer-protection finding.
- When a source confirms it, your report is linked to a Red List entry. Your name and contact details stay private.